Search results for "ARTHRITIS"

showing 10 items of 1029 documents

PAIN RELIEF AND FUNCTIONAL RECOVERY OVER A SIX-MONTH PERIOD AFTER INTRA - ARTICULAR INJECTION WITH SODIUM HYALURONATE ( MW 1500-2000KDA) IN OSTEOARTH…

2014

Settore M-EDF/02 - Metodi E Didattiche Delle Attivita' SportiveHYALURONICACID VISCOSUPPLEMENTATION KNEE OSTEOARTHRITIS ULTRAOUND-GUIDED INTRA ARTICULAR INJECTION
researchProduct

Effects of physical activity on postural balance in children with juvenile idiopathic arthritis: results from pilot study

2017

Settore M-EDF/02 - Metodi E Didattiche Delle Attivita' Sportivebody balance postural control physical activity idiopathic arthritis children
researchProduct

INTEGRATIVE MEDICINE

2010

Settore MED/09 - Medicina Internaaging chronic disease cardiovascular disease diabetes osteoarthritis
researchProduct

Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry

2023

AbstractThis study aims to describe musculoskeletal manifestations (MSM) in children with Behçet’s syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Behçet’s Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67.6%) and pseudofolliculitis (56.8%) were the most common symptoms associated with MSM. At disease onset, 31 subjects had arthritis (83.8%), 33 arthralgia (89.2%), and 14 myalgia (…

Settore MED/16 - REUMATOLOGIABehçet's diseaseBehçet’s syndromeArthritisArthritis; Behçet’s syndrome; International registry; Pediatric rheumatology; Rare diseasesRare diseasesSettore MED/38 - Pediatria Generale E SpecialisticaArthritis Behçet’s syndrome International registry Pediatric rheumatology Rare diseasesInternational registryEmergency MedicineInternal MedicineAutoinflammationPediatric rheumatologyArthriti
researchProduct

Reply

2017

Settore MED/16 - ReumatologiaArthritis PsoriaticInterleukin-9Human
researchProduct

IL-17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL-25-Driven Intestinal Inflammation

2020

To characterize the ecological effects of biologic therapies on the gut bacterial and fungal microbiome of psoriatic arthritis (PsA)/spondyloarthritis (SpA) patients.

Settore MED/16 - ReumatologiaIL-17 inhibitorPsoriatic arthritiSpondyloarthritisMicrobiomeCandida
researchProduct

Co-morbidities in patients with hip osteoarthritis and treated with ecoguided infiltrations of Hyaluronic acid: study of the effectiveness of the tre…

2014

Settore MED/33 - Malattie Apparato Locomotoreosteoarthritis co-morbidities ecoguided infiltrations hyaluronic acid
researchProduct

The effectiveness of eco-guided infiltrations with high molecular weight associated with administration of oral chondroprotective supplements in oste…

2012

Osteoarthritis does not mean a degenerative articular process only but a pathologic expression of wear, inflammation and immunological imbalance of the joints. Our study has the aim to demonstrate the effectiveness of eco-guidate infiltrations with high molecular weight associated with administration of oral chondroprotective supplements (glucosamine solfate, chondroitin sulphate, hydrolyzed collagen type II, hyaluronic acid and L carnitine fumarate) in comparison with the only treatment with ecoguided infiltrations with hyaluronic acid in patients suffering from primary osteoarthiritis of the hip.

Settore MED/34 - Medicina Fisica E Riabilitativaosteoarthritis hip infiltration chondroprotective supplement
researchProduct

Anakinra drug retention rate and predictive factors of drug survival in systemic juvenile idiopathic arthritis and adult onset Still’s disease.

2019

Introduction: Only a few studies have reported the long-term efficacy of interleukin (IL)-1 inhibition in systemic juvenile idiopathic arthritis (sJIA) and adult onset Still’s disease (AOSD). We herein describe Anakinra (ANA) effectiveness expressed in terms of drug retention rate (DRR) and evaluate predictive factors of drug survival in sJIA and ASOD patients. Objectives: Examine the overall DRR of ANA in sJIA and AOSD patients. Explore the influence of biologic line of treatment, and the concomitant use of disease modifying anti-rheumatic drugs (cDMARDs) on DRR in the whole sample and stratified according to the disease thereafter; find eventual predictive factors associated with events l…

Settore MED/38 - Pediatria Generale E SpecialisticaAnakinraSettore MED/16 - REUMATOLOGIAAnakinra Systemic Juvenile Idiopathic Arthritis Still’s disease
researchProduct

Dermatologic adverse events associated with Juvenile Idiopathic Arthritis treatment

2020

Introduction: Steroids and disease-modifying anti-rheumatic drugs (DMARDs) are widely used in the treatment of juvenile idiopathic arthritis (JIA). Dermatologic adverse events including psoriasis have been reported in treatment of various inflammatory diseases (1-3). However, data regarding the occurrence of dermatologic adverse events in JIA patients are scarce (4-6). Objectives: To determine the prevalence of dermatologic adverse events in JIA patients treated with systemic steroids and DMARDs. To investigate an association between drugs and dermatologic adverse events and the association between anti-TNF treatment and psoriasiform lesions.

Settore MED/38 - Pediatria Generale E SpecialisticaDMARDs juvenile idiopathic arthritis Dermatologic adverse events
researchProduct